These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31459966)

  • 1. Molecular Modeling-
    Maki MAA; Kumar PV; Cheah SC; Siew Wei Y; Al-Nema M; Bayazeid O; Majeed ABBA
    ACS Omega; 2019 May; 4(5):8767-8777. PubMed ID: 31459966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin inclusion complex inhibits circulating galectin-3 and FGF-7 and affects the reproductive integrity and mobility of Caco-2 cells.
    Maki MAA; Cheah SC; Bayazeid O; Kumar PV
    Sci Rep; 2020 Oct; 10(1):17468. PubMed ID: 33060727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytotoxic effect of palladium (II) inclusion compounds in beta-cyclodextrin].
    Jaimes N; Salmen S; Colmenares MC; Burgos AE; Tamayo L; Mendoza RV; Cantor A
    Biomedica; 2016 Dec; 36(4):603-611. PubMed ID: 27992987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complex of GA-13316 with β-cyclodextrin: preparation, characterization, molecular modeling, and in vitro evaluation.
    Yang R; Chen JB; Xiao CF; Liu ZC; Gao ZY; Yan SJ; Zhang JH; Zhang HB; Lin J
    Carbohydr Polym; 2014 Oct; 111():655-62. PubMed ID: 25037400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line.
    Daruházi AE; Kiss T; Vecsernyés M; Szente L; Szőke E; Lemberkovics E
    J Pharm Biomed Anal; 2013 Oct; 84():112-6. PubMed ID: 23810850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells].
    Kiss T; Fenyvesi F; Kovácsné BI; Fehér P; Leposáné KR; Váradi J; Szente L; Fenyvesi E; Iványi R; Vecsernyés M
    Acta Pharm Hung; 2007; 77(2):150-4. PubMed ID: 17933275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
    Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
    Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lidocaine and the inclusion complex with 2-hydroxypropyl-β-cyclodextrin on cell viability and proliferation of oral squamous cell carcinoma.
    Ferreira LEN; Antunes GBM; Muniz BV; Burga-Sánchez J; de Melo NFS; Groppo FC; Fraceto LF; Volpato MC
    J Pharm Pharmacol; 2018 Jul; 70(7):874-882. PubMed ID: 29633269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
    Paul S; Heng PW; Chan LW
    J Pharm Pharmacol; 2016 Apr; 68(4):439-49. PubMed ID: 26946047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of thiolated β-cyclodextrin as a novel mucoadhesive excipient for intra-oral drug delivery.
    Ijaz M; Matuszczak B; Rahmat D; Mahmood A; Bonengel S; Hussain S; Huck CW; Bernkop-Schnürch A
    Carbohydr Polym; 2015 Nov; 132():187-95. PubMed ID: 26256340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion complexes of tea polyphenols with HP-β-cyclodextrin:Preparation, characterization, molecular docking, and antioxidant activity.
    Zhong Y; Li W; Ran L; Hou R; Han P; Lu S; Wang Q; Zhao W; Zhu Y; Dong J
    J Food Sci; 2020 Apr; 85(4):1105-1113. PubMed ID: 32175596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor targeted bufalin/β-cyclodextrin supramolecular inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin.
    Zou A; Zhao X; Handge UA; Garamus VM; Willumeit-Römer R; Yin P
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():609-618. PubMed ID: 28576029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
    Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
    J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
    Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
    Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into the inclusion complexes between clomiphene citrate and β-cyclodextrin: The mechanism of preferential isomeric selection.
    Maheshwari A; Saraswat H; Upadhyay SK
    Chirality; 2017 Aug; 29(8):451-457. PubMed ID: 28644553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin modulates the cytotoxic effects of chlorhexidine on microrganisms and cells in vitro.
    Teixeira KI; Denadai AM; Sinisterra RD; Cortés ME
    Drug Deliv; 2015 May; 22(3):444-53. PubMed ID: 24491181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.